FRBA(FRBA)
FRBA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $149M | $156M |
| Low | $148M | $155M |
| High | $150M | $156M |
| EBITDA Avg | $48M | $50M |
| Low | $48M | $50M |
| High | $48M | $50M |
| EBIT Avg | $46M | $48M |
| Low | $45M | $47M |
| High | $46M | $48M |
| Net Income Avg | $40M | $45M |
| Low | $40M | $44M |
| High | $41M | $48M |
| EPS Avg | $1.62 | $1.83 |
| Low | $1.59 | $1.75 |
| High | $1.64 | $1.90 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $38M | $38M | $38M | $39M | $39M | $40M |
| Low | $38M | $38M | $38M | $39M | $39M | $40M |
| High | $38M | $38M | $38M | $39M | $39M | $40M |
| EBITDA Avg | $12M | $12M | $12M | $12M | $13M | $13M |
| Low | $12M | $12M | $12M | $12M | $13M | $13M |
| High | $12M | $12M | $12M | $12M | $13M | $13M |
| EBIT Avg | $12M | $12M | $12M | $12M | $12M | $12M |
| Low | $11M | $12M | $12M | $12M | $12M | $12M |
| High | $12M | $12M | $12M | $12M | $12M | $12M |
| Net Income Avg | $11M | $11M | $11M | $11M | $12M | $12M |
| Low | $11M | $11M | $11M | $11M | $12M | $12M |
| High | $11M | $11M | $11M | $11M | $12M | $12M |
| EPS Avg | $0.44 | $0.44 | $0.43 | $0.45 | $0.47 | $0.48 |
| Low | $0.43 | $0.44 | $0.43 | $0.45 | $0.47 | $0.48 |
| High | $0.45 | $0.45 | $0.44 | $0.45 | $0.47 | $0.48 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |